Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: Comparison of intravenous and intramuscular drug administration

European Radiology

Volumn 22, Issue 6, 2012, Pages 1186-1194

  Gutzeit, Andreas ^a,b   Binkert, Christoph A ^a   Koh, Dow Mu ^c   Hergan, Klaus ^b   Von Weymarn, Constantin ^a   Graf, Nicole ^d   Patak, Michael A ^d   Roos, Justus E ^a   Horstmann, Marcus ^a   Kos, Sebastian ^e   Hungerbühler, Simone ^a   Froehlich, Johannes M ^a  

^a CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Anti peristaltic effect; Gastrointestinal motility; Glucagon; Hyoscine N butylbromide; Small bowel

Indexed keywords

GLUCAGON; SCOPOLAMINE; SCOPOLAMINE BUTYL BROMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DRUG EFFICACY; FEMALE; HUMAN; IMAGE PROCESSING; INTESTINE MOTILITY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMALL INTESTINE; SPASMOLYSIS;

ADULT; ANTIDIARRHEALS; FEMALE; GASTROINTESTINAL MOTILITY; GLUCAGON; HUMANS; IMAGE ENHANCEMENT; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INTESTINE, SMALL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SCOPOLAMINE HYDROBROMIDE; SENSITIVITY AND SPECIFICITY;

EID: 84861521227     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2366-1     Document Type: Article

References (17)

1. Husebye E (1999) The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil 11:141-161 (Pubitemid 29259606)
2. Kozak RI, Bennett JD, Brown TC, Lee TY (1994) Reduction of bowel motion artifact during digital subtraction angiography: a comparison of hyoscine butylbromide and glucagon. Can Assoc Radiol J 45:209-211 (Pubitemid 24225111)
3. Laniado M, Grönewäller E, Kopp AF et al (1997) The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles. Abdom Imaging 22:381-388 (Pubitemid 27272814)
4. Johnson W, Taylor MB, Carrington BM, Bonington SC, Swindell R (2007) The value of hyoscine butylbromide in pelvic MRI. Clin Radiol 62:1087-1093 (Pubitemid 47500662)
5. Martí-Bonmatí L, Graells M, Ronchera-Oms CL (1996) Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: a comparative evaluation of three drugs. Abdom Imaging 2:309-313 (Pubitemid 26230765)
6. Wagner M, Klessen C, Rief M et al (2008) High-resolution T2- weighted abdominal magnetic resonance imaging using respiratory triggering: impact of butylscopolamine on image quality. Acta Radiol 49:376-382 (Pubitemid 351598790)
7. Mayo KE, Miller LJ, Bataille D et al (2003) International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55:167-194 (Pubitemid 36268402)
8. Dubé PE, Brubaker PL (2007) Frontiers in glucagon-like peptide- 2: multiple actions, multiple mediators. Am J Physiol Endocrinol Metab 293:E460-E465 (Pubitemid 47205088)
9. Tytgat GN (2008) Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. Curr Med Res Opin 24:3159-3173
10. Huizinga JD, McKay CM, White EJ (2006) The many facets of intestinal peristalsis. Am J Physiol Gastrointest Liver Physiol 290: G1347-G1349
11. Stone AJ, Browne JE, Lennon B, Meaney JF, Fagan AJ (2011) Stone Quantification of accuracy of ADC measurements from Whole-body DWIBS. Proc Intl Soc Mag Reson Med 19:836
12. Rowland-Hill CA, Loveday EJ, Thomas ML (1989) A comparison of the value of hyoscine butylbromide and glucagons on aorto iliac intravenous digital subtraction. Vasa 18:301-303 (Pubitemid 20039843)
13. Rogalla P, Lembcke A, Rückert JC et al (2005) Spasmolysis at CT colonography: butyl scopolamine versus glucagon. Radiology 236:184-188 (Pubitemid 40853311)
14. Gutzeit A, Patak MA, von Weymarn C et al (2010) Feasibility of small bowel flow rate measurement with MRI. J Magn Reson Imaging 32:345-351
15. Froehlich JM, Daenzer M, von Weymarn C et al (2009) Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imaging. Eur Radiol 19:1387-1393
16. Froehlich JM, Patak MA, von Weymarn C, Juli CF, Zollikofer CL, Wentz KU (2005) Small bowel motility assessment with magnetic resonance imaging. J Magn Reson Imaging 21:370-375 (Pubitemid 40446431)
17. Wakamiya M, Furukawa A, Kanasaki S, Murata K (2011) Assessment of small bowel motility function with cine-MRI using balanced steady-state free precession sequence. J Magn Reson Imaging 33:1235-1240